Flu A/B Rapid Test – EZER™ Influenza Antigen Device
The EZER™ Flu A+B Antigen Rapid Test is a high-performance lateral flow immunoassay for the rapid, qualitative detection of Flu A/B nucleoprotein antigens in nasopharyngeal (NP) swabs, throat swabs, and nasal aspirate samples. This test enables fast differentiation between influenza A and B infections within 15 minutes, aiding early clinical decision-making in seasonal outbreaks or high-risk settings. Designed for professional use, the assay employs monoclonal antibodies specific to Flu A and B nucleoproteins. A visual result is displayed through distinct red lines in test zones for Influenza A (A), Influenza B (B), and a control zone (C). Results may appear as early as 3 minutes but must be confirmed at 15 minutes. The EZER™ Flu A/B test delivers >99% agreement with cell culture and is validated across sample types. With excellent specificity and sensitivity, it ensures confidence in early detection and triage. Manufactured by Genesis Biotech, this kit is ideal for laboratories requiring rapid influenza screening tools that meet international quality standards.
Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.
This kit in detail
The EZER™ Flu A+B Antigen Rapid Test is a high-performance lateral flow immunoassay for the rapid, qualitative detection of Flu A/B nucleoprotein antigens in nasopharyngeal (NP) swabs, throat swabs, and nasal aspirate samples. This test enables fast differentiation between influenza A and B infections within 15 minutes, aiding early clinical decision-making in seasonal outbreaks or high-risk settings.
Designed for professional use, the assay employs monoclonal antibodies specific to Flu A and B nucleoproteins. A visual result is displayed through distinct red lines in test zones for Influenza A (A), Influenza B (B), and a control zone (C). Results may appear as early as 3 minutes but must be confirmed at 15 minutes.
The EZER™ Flu A/B test delivers >99% agreement with cell culture and is validated across sample types. With excellent specificity and sensitivity, it ensures confidence in early detection and triage.
Manufactured by Genesis Biotech, this kit is ideal for laboratories requiring rapid influenza screening tools that meet international quality standards.
- Flu A/B-specific – Simultaneous detection of Influenza A and B antigens
- Quick results – Visual interpretation in just 15 minutes
- Flexible sample types – NP swab, throat swab, or nasal aspirate
- High accuracy – 99.65% agreement with gold-standard methods
What is in the Flu A/B Rapid Test?
Each kit contains 20 individually sealed EZER™ Flu A+B test cassettes, swabs, extraction tubes with buffer, nozzles, a stand, and a package insert. The test uses a sandwich-format immunochromatographic membrane to detect Flu A/B viral nucleoproteins.
The sample reacts with colloidal gold-labeled antibodies in the reagent pad. If antigens are present, immune complexes form and bind to test lines marked A and B. A visible red line indicates a positive result for either Flu A, Flu B, or both.
Role of Flu A/B in Disease
Influenza A and B are single-stranded RNA viruses responsible for annual respiratory illness outbreaks:
-
Influenza A: Highly transmissible; associated with pandemics and severe epidemics
-
Influenza B: Causes seasonal flu; typically milder but can cause serious illness in vulnerable populations
-
Flu A/B co-circulation is common during flu seasons, making dual detection critical
Rapid identification allows early initiation of antiviral therapy-particularly effective if administered within 48 hours of symptom onset. Discriminating between Flu A and B is essential for managing transmission and choosing the appropriate antiviral regimen.
About the EZER™ Flu A+B Antigen Rapid Test
The EZER™ Flu A+B Rapid Test is an immunochromatographic assay designed for fast detection of Flu A/B antigens using monoclonal antibodies. Key assay characteristics:
-
Detects nucleoprotein antigens specific to each virus type
-
Distinct visual readout for Flu A (line A) and Flu B (line B)
-
Internal control line (C) ensures proper test performance
-
Compatible with room temperature testing (15–30 °C)
Performance Summary:
-
Flu A Sensitivity: Up to 97.56% (nasal aspirates)
-
Flu B Sensitivity: Up to 100% (nasopharyngeal swabs)
-
Specificity (A & B): >99.4%
-
Overall Accuracy: >99.0% across sample types
Principle and Workflow
Test Principle:
-
Sample migrates along membrane strip
-
If present, Flu A/B antigens bind to gold-labeled monoclonal antibodies
-
Complex is captured by immobilized antibodies in the test zones (A & B)
-
Control line (C) confirms proper flow and assay validity
Procedure:
-
Prepare sample using NP swab, throat swab, or nasal aspirate
-
Insert sample into extraction tube with buffer
-
Mix and apply 3 drops (100 µL) to the sample well
-
Read results at 15 minutes
Result Interpretation:
-
A line only: Influenza A positive
-
B line only: Influenza B positive
-
A + B lines: Dual infection
-
C line only: Negative
-
No C line: Invalid test
Clinical Application
The EZER™ Flu A+B Rapid Test is a valuable tool for:
-
Emergency and primary care settings for acute respiratory illness
-
Outbreak control in institutional or community settings
-
Influenza surveillance in clinical microbiology laboratories
-
Triage and rapid decision-making in hospitals or urgent care units
Its combination of speed, accuracy, and ease-of-use makes it a practical alternative to PCR during peak flu seasons when rapid testing throughput is required.
Datasheets and regulatory documentation
Everything your quality team needs for evaluation and procurement.
Add this kit to your quote
Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.

